Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2019.118775
Abstract: In the present study, we successfully developed Cetuximab-conjugated modified citrus pectin-chitosan nanoparticles for targeted delivery of curcumin (Cet-MCPCNPs) for the treatment of colorectal cancer. In vitro analysis revealed that the resulted nanoparticles were spherically shaped… read more here.
Keywords: cetuximab conjugated; conjugated chitosan; cet mcpcnps; cancer ... See more keywords